NLS Pharmaceutics AG (NLSPW)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.01

0.00%

After-hours Dec 13, 2024, 03:41 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Revenue	-	-	-	-	-	-	-
Cost of Revenue	11.41K	11.41K	10.05K	-	-	-	-
Gross Profit	-11.41K	-11.41K	-10.05K	-	-	-	-
Operating Income	-11.81M	-15.48M	-11.86M	-2.30M	-4.20M	-3.45M	-5.77M
Interest Income	-	100.87	68.13	233.70	819.71	16.04K	890.40
Pretax Income	-12.17M	-16.50M	-11.95M	-2.86M	-5.45M	-5.15M	-6.66M
Net Income	-12.17M	-16.50M	-11.95M	-2.86M	-5.45M	-5.15M	-6.66M
Selling & General & Admin	5.90M	6.49M	5.93M	2.20M	2.49M	2.01M	1.44M
Research & Development	5.91M	8.98M	5.92M	99.58K	1.70M	1.44M	4.32M
Other Expenses	0.00	10.04K	-17.32K	-328.37K	-	-629.23K	-
Operating Expenses	11.81M	15.47M	11.85M	2.30M	4.20M	3.45M	5.77M
Interest Expense	145.15K	100.87K	68.13K	233.70K	819.71K	1.07M	890.40K
Selling & Marketing Expenses	-	6.49M	5.93M	2.20M	2.49M	-	-
Cost & Expenses	11.81M	15.48M	11.86M	2.30M	4.20M	3.45M	5.77M
Income Tax	-	2.00	-226.51K	-2.30K	-4.20K	1.70M	-5.77K
Shares Outstanding (Basic)	38.18M	19.68M	14.75M	4.82M	11.14M	11.78M	11.78M
Shares Outstanding (Diluted)	38.18M	19.68M	14.75M	4.82M	11.14M	11.78M	11.78M
EPS (Basic)	-0.32	-0.84	-0.81	-0.59	-0.49	-0.44	-0.57
EPS (Diluted)	-0.32	-0.84	-0.81	-0.59	-0.49	-0.44	-0.57
EBITDA	-11.80M	-15.47M	-11.85M	-	-430.40K	-613.20K	-5.77M
Depreciation & Amortization	11.41K	11.41K	10.05K	2.30M	4.20M	3.45M	5.77M